Table 2.
Treatment regimens
| All patients (n = 89) | Age ≥80 y (n = 49) | Underwent surgery∗ (n = 21) | |
|---|---|---|---|
| Intent, n (%) | |||
| CRT without preoperative intent | 52 (58) | 33 (67) | 0 (0) |
| CRT with preoperative intent | 29 (33) | 11 (22) | 21 (100) |
| Definitive radiation alone | 5 (6) | 3 (6) | 0 (0) |
| Postoperative radiation | 3 (3) | 2 (4) | 0 (0) |
| Chemotherapy, n (%) | |||
| Carboplatin-paclitaxel | 41 (46) | 22 (45) | 15 (71) |
| Platinum-fluoropyrimidine | 27 (30) | 12 (24) | 6 (29) |
| Fluoropyrimidine alone | 14 (16) | 11 (22) | 0 (0) |
| Other | 2 (2) | 1 (2) | 0 (0) |
| None | 5 (6) | 3 (6) | 0 (0) |
| Radiation | |||
| Dose, median (range) | 50 Gy (45-66 Gy) | 50 Gy (50-60 Gy) | 50 Gy (45-55.8 Gy) |
| IMRT modality | 68 (76%) | 39 (80%) | 17 (81%) |
Abbreviations: CRT = chemoradiation; IMRT = intensity modulated radiation therapy.
∗
Underwent preoperative chemoradiation and surgery. Excludes those who underwent upfront surgery and postop radiation.